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islands SPI-13 and SPI-8 in the interaction 
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Abstract 
Background: Salmonella pathogenicity island (SPI)‑13 is conserved in many serovars of S. enterica, including S. Ente‑
ritidis, S. Typhimurium and S. Gallinarum. However, it is absent in typhoid serovars such as S. Typhi and Paratyphi A, 
which carry SPI‑8 at the same genomic location. Because the interaction with macrophages is a critical step in Salmo-
nella pathogenicity, in this study we investigated the role played by SPI‑13 and SPI‑8 in the interaction of S. Enteritidis 
and S. Typhi with cultured murine (RAW264.7) and human (THP‑1) macrophages.
Results: Our results showed that SPI‑13 was required for internalization of S. Enteritidis in murine but not human 
macrophages. On the other hand, SPI‑8 was not required for the interaction of S. Typhi with human or murine mac‑
rophages. Of note, the presence of an intact copy of SPI‑13 in a S. Typhi mutant carrying a deletion of SPI‑8 did not 
improve its ability to be internalized by, or survive in human or murine macrophages.
Conclusions: Altogether, our results point out to different roles for SPI‑13 and SPI‑8 during Salmonella infection. 
While SPI‑13 contributes to the interaction of S. Enteritidis with murine macrophages, SPI‑8 is not required in the inter‑
action of S. Typhi with murine or human macrophages. We hypothesized that typhoid serovars have lost SPI‑13 and 
maintained SPI‑8 to improve their fitness during another phase of human infection.
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Background
The genus Salmonella comprises more than 2500 sero-
vars distributed in two species, S. bongori and S. enterica 
[1, 2]. Some serovars are able to infect a broad range of 
hosts (generalists), while others only cause disease in a 
particular host (specialists). S. Enteritidis is a general-
ist serovar that infects mammals and birds causing a 
typhoid-like infection in susceptible mice and asympto-
matic carriage in hens. In humans, it represents a major 
cause of foodborne gastroenteritis [3, 4]. Conversely, S. 
Typhi is a specialist serovar that infects only humans, 
causing the systemic disease typhoid fever [5, 6].
Most genes required for Salmonella pathogenicity 
are clustered in genomic islands known as Salmonella 
pathogenicity islands (SPIs). So far, 23 SPIs have been 
described and characterized [7–11]. Five SPIs (SPI-1 to 
SPI-5) are common to all serovars of S. enterica, while the 
rest is distributed among different serovars and/or strains 
[7–11]. One such example is SPI-13, which is present 
in many S. enterica serovars including S. Enteritidis, S. 
Typhimurium, S. Cholerasuis and S. Gallinarum, but it is 
absent in S. Typhi and S. Paratyphi A, which carry SPI-8 
in the same genomic location, adjacent to the tRNA-pheV 
gene [8, 9, 12] (Fig. 1). The number of genes within SPI-
13 is not clearly defined; different authors have reported 
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that it contains 4 [8], 18 [13] or 22 ORFs [9]. In this study 
we defined SPI-13 as the region including genes SEN2960 
to SEN2966 of S. Enteritidis because they are flanked by 
nearly perfect direct repeats. In addition, these are the 
genes replaced in S. Typhi by SPI-8, which includes genes 
STY3273 to STY3292 [14].
It has been reported that genes in SPI-13 from S. Typh-
imurium [15–17] and S. Enteritidis [18] are expressed 
within macrophages in  vitro, and are required for sys-
temic infection in mice [9, 19–22]. These genes are hom-
ologues to the ripABC operon of Yersinia pestis, which 
encodes proteins required for the degradation of itaco-
nate produced by macrophages during infection [23].
In comparison to SPI-13, much less information is 
available on SPI-8. In S. Typhi, this pathogenicity island 
contains a degenerate integrase gene, two bacteriocin 
pseudogenes and intact genes encoding proteins confer-
ring immunity to these bacteriocins [14]. In addition, 
STY3280 has been shown to be expressed within human 
macrophages [24].
In this study, we investigated the roles of SPI-13 and 
SPI-8 in the interaction of S. Enteritidis and S. Typhi with 
cultured murine and human macrophages. Previously, 
other authors have demonstrated that both serovars are 
internalized by murine macrophages; but only S. Ente-
ritidis is able to survive intracellularly [25]. In contrast, 
S. Enteritidis has a low ability to survive intracellularly in 
human macrophages, whereas S. Typhi survives and pro-
liferates for long periods, showing less cytotoxicity than 
other serovars [25]. We hypothesized that the differential 
distribution of SPI-13 and SPI-8 in these two serovars 
might drive, in part, the different phenotypes observed 
in vitro in macrophages of different origins.
Methods
Bacterial strains, media, and growth conditions
Bacterial strains used in this study are listed in Table 1. 
All S. Enteritidis and S. Typhi strains are derivatives 
of wild-type strains NCTC13349 [13] and STH2370 
[26], respectively. Bacteria were routinely grown in 
Fig. 1 Comparison of the genomic region that includes SPI‑13 in S. Enteritidis NCTC13349 and SPI‑8 in S. Typhi CT18. A DNA‑based comparison 
was performed by BLASTN analysis with WebACT (http://www.webact.org/WebACT/home) and visualized with ACT software. Homology between 
sequences (>98% identity) is highlighted in red. Green boxes correspond to tRNA‑pheV genes and white boxes correspond to pseudogenes
Table 1 Bacterial strains used in the present study
Strain Phenotype/genotype Source or reference
Salmonella
S. Enteritidis NCTC13349 Wild‑type strain [13]
S. Enteritidis ∆SPI‑13 NCTC13349 ∆(SEN2960‑SEN2966)::FRT This study
S. Enteritidis ∆SPI‑13/pSPI‑13 NCTC13349 ∆(SEN2960‑SEN2966)::FRT/pBAD‑TOPO::(SEN2960‑SEN2966) This study
S. Typhi STH2370 Wild‑type strain [26]
S. Typhi ∆SPI‑8 STH2370 ∆(STY3273‑STY3292)::FRT This study
S. Typhi ∆SPI‑8/pSPI‑8 STH2370 ∆(STY3273‑STY3292)::FRT/pBAD‑TOPO::(STY3273‑STY3292) This study
S. Typhi ∆SPI‑8/pSPI‑13 STH2370 ∆(STY3273‑STY3292)::FRT/pBAD‑TOPO::(SEN2960‑SEN2966) This study
Escherichia coli
TOP10 K12 F− Ф80lacZ∆M15 ∆(lacZYA‑argF)U169 deoR recA1 endA1 hsdR17(rk−, mk+) phoA supE44 thi–1 
gyrA96 relA1 λ−
Invitrogen
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Luria–Bertani (LB) medium (10  g/L tryptone, 5  g/L 
yeast extract, 5 g/L NaCl) at 37 °C with agitation. When 
required, LB medium was supplemented with ampicillin 
(Amp; 100  mg/L) or kanamycin (Kan; 50  mg/L). Media 
were solidified by the addition of agar (15 g/L).
Construction of mutant strains
All mutant strains were constructed by the Red-swap 
method [27] with modifications [21], using plasmid 
pCLF4 (KanR, GenBank accession number EU629214) as 
template and specific primers listed in Additional file 1: 
Table S1. The Kan-resistance cassette introduced by this 
procedure was eliminated by recombination using the 
FLP helper plasmid pCP20 [27, 28]. Each mutation was 
confirmed by PCR amplification using primers flanking 
the sites of substitution (Additional file 1: Table S1).
Construction of plasmids
SPI-13 and SPI-8 were amplified from strains 
NCTC13349 and STH2370, respectively, using PfuUltra 
II high-fidelity DNA polymerase (Stratagene) and spe-
cific primers listed in Additional file  1: Table S1. Each 
PCR product was purified from 1% agarose gels using the 
“QIAquick Gel Extraction Kit” (QIAGEN). Purified PCR 
products were adenylated at the 3′ end and cloned into 
pBAD-TOPO using the “pBAD-TOPO TA Expression 
Kit” (Invitrogen). Recombinant plasmids pSPI-13 and 
pSPI-8 were transformed into competent E. coli TOP10 
(Invitrogen). The presence and orientation of the insert in 
each plasmid was confirmed by PCR amplification using 
primers listed in Additional file 1: Table S1. Finally, differ-
ent strains of S. Enteritidis and S. Typhi were transformed 
by electroporation with these plasmids for complementa-
tion assays.
Cell lines and culture conditions
RAW264.7 murine macrophages were grown as mon-
olayers in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS). THP-1 
human monocytes were grown in suspension using 
RPMI-1640 medium supplemented with 2  mM  l-glu-
tamine, 10% FBS and 50  μM β-mercaptoethanol. Both 
cell lines were maintained in an air-jacketed incubator 
(NuAire) at 37 °C in the presence of 5% CO2.
Bacterial infection assays
For infection assays using RAW264.7 macrophages, mon-
olayers were prepared by seeding ~2.5 × 105 cells/well in 
48-well plates (Nunc) and incubating for 20 h at 37 °C in 
a 5% CO2 atmosphere. From each bacterial culture grown 
overnight in LB at 37 °C with agitation, a 1/100 dilution in 
5 mL of LB was prepared, and grown under the same con-
ditions until reaching an OD600 = 0.4–0.6. Then, bacteria 
were centrifuged and washed with phosphate buffered 
saline (PBS), suspended in 100 μL of DMEM and added 
to the macrophages at a multiplicity of infection (MOI) 
of ~50 bacteria/cell. After 45 min of incubation at 37 °C, 
macrophages were washed three times with PBS contain-
ing 200 mg/L gentamicin and further incubated for 1 h in 
DMEM containing 200 mg/L gentamicin to kill extracel-
lular bacteria. Then, cells from three wells were washed 
with PBS, and lysed with 0.5% sodium deoxycholate. 
Internalized bacteria were enumerated by serial dilution 
and plating on LB agar. The percentage of internalization 
was calculated as follows: 100 × (CFUinternalized/CFUinocu-
lum). In the remaining six wells, medium was replaced by 
DMEM containing 20  mg/L gentamicin and cells were 
incubated for 2 h (three wells) or 20 h (three wells). Then, 
cells were washed, lysed and CFU were determined as 
described. The percentage of intracellular survival was 
calculated as follows: 100 × (CFU2 or 20h/CFUinternalized).
For infection assays using THP-1 monocytes, 
~5  ×  105  cells were seeded in 1.7  mL tubes and incu-
bated for 20  h at 37  °C in a 5% CO2 atmosphere. Bac-
teria were grown as indicated above, washed with 
PBS and suspended in 100  μL of RPMI-FBS without 
β-mercaptoethanol. THP-1 cells were spun down and 
the bacterial suspension was added, resulting in a MOI 
of ~50 bacteria/cell. Internalization and intracellular sur-
vival were determined as described above.
Cytotoxicity assays
To determine the cytotoxicity produced by Salmonella 
strains during macrophage infection, lactate dehydro-
genase (LDH) release was measured using “CytoTox96 
Non-Radioactive Cytotoxicity Assay” (Promega), as rec-
ommended by the manufacturer.
Statistical analysis
Statistical significance of differences in the data was 
determined via one-way ANOVA with Dunnett’s test 
using the GraphPad Prism v6.0 software.
Results
SPI‑13 is required for S. Enteritidis internalization in murine 
macrophages
It has been shown that several SPI-13 genes contribute 
to Salmonella pathogenesis in mice and chickens [9, 12, 
19–22]. Because survival within macrophages is a crucial 
step in Salmonella systemic infection, we evaluated the 
contribution of SPI-13 in the interaction of S. Enteritidis 
with RAW264.7 macrophages. To this end, we tested the 
ability of the wild-type strain NCTC13349, an isogenic 
∆SPI-13 mutant and the mutant complemented in trans 
with an intact copy of SPI-13, to be internalized by and 
survive within RAW264.7 macrophages. Our results 
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showed that deletion of SPI-13 significantly impaired S. 
Enteritidis internalization in comparison to the wild-type 
strain. This phenotype was reverted by the introduction 
of a plasmid carrying an intact copy of SPI-13 (Fig.  2). 
On the other hand, deletion of SPI-13 did not affect S. 
Enteritidis survival after 2 or 20  h of infection (Fig.  2). 
The presence of the empty vector did not alter the phe-
notypes observed for the wild-type strain or the ∆SPI-13 
mutant in our infection assays (data not shown). In addi-
tion, all strains showed similar cytotoxicity to RAW264.7 
macrophages, as evaluated by LDH release during infec-
tions (data not shown).
SPI‑8 is not required for S. Typhi internalization or 
intracellular survival in murine macrophages
To determine the role played by SPI-8 in the interaction 
of S. Typhi with murine macrophages, we tested the abil-
ity of the wild-type strain STH2370, an isogenic ∆SPI-8 
mutant and the mutant complemented in trans with 
an intact copy of SPI-8, to be internalized by and sur-
vive within RAW264.7 cells. No significant differences 
compared to the wild type were found when the ∆SPI-8 
mutant and the complemented strain were analyzed 
(Fig. 3). In addition, the presence/absence status of SPI-8 
did not affect the cytotoxicity of S. Typhi on RAW264.7 
macrophages (data not shown).
In view of our results with S. Enteritidis (Fig.  2), we 
tested if the presence of SPI-13 could improve the inter-
nalization or survival of S. Typhi ∆SPI-8 within murine 
macrophages. To do this, we performed infection assays 
using the S. Typhi ∆SPI-8 mutant carrying an intact copy 
of SPI-13. Our results showed that the presence of SPI-
13 did not increase the internalization or intracellular 
survival of S. Typhi ∆SPI-8 in RAW264.7 macrophages 
(Fig. 3). Furthermore, the presence of this island did not 
affect the cytotoxicity of S. Typhi ∆SPI-8 on RAW264.7 
macrophages (data not shown).
Neither SPI‑8 nor SPI‑13 contribute to the internalization 
or intracellular survival of S. Typhi and S. Enteritidis 
in human macrophages
Next, we aimed to determine whether SPI-13 and SPI-8 
contribute to the internalization or intracellular survival 
of S. Enteritidis and S. Typhi, respectively, in human 
Fig. 2 Contribution of SPI‑13 to the internalization and intracellular survival of S. Enteritidis in murine macrophages. Infection assays were 
conducted as described in “Methods” section to determine the internalization and intracellular survival of S. Enteritidis strains in RAW264.7 mac‑
rophages. Graphics show mean values of at least 3 independent assays ± SEM. Statistical significance was determined using a one‑way ANOVA with 
Dunnett’s test (*P < 0.05)
Fig. 3 Contribution of SPI‑8 and SPI‑13 to the internalization and intracellular survival of S. Typhi in murine macrophages. Infection assays were 
conducted as described in “Methods” section to determine the internalization and intracellular survival of S. Typhi strains in RAW264.7 macrophages. 
Graphics show mean values of at least 3 independent assays ± SEM. Statistical significance was determined using a one‑way ANOVA with Dunnett’s 
test
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macrophages. To do this, we first performed infection 
assays in THP-1 human macrophages using wild-type S. 
Enteritidis, the ∆SPI-13 mutant, and the mutant comple-
mented in trans with an intact copy of SPI-13. We did not 
observe differences in internalization, intracellular sur-
vival (Fig. 4a) and cytotoxicity (data not shown) between 
the wild-type strain and the mutants tested. Similar 
results were obtained when THP-1 macrophages were 
infected with wild-type S. Typhi, the ∆SPI-8 mutant, and 
the mutant complemented in trans with an intact copy of 
SPI-8 (Fig. 4b).
Discussion
Although SPI-13 was identified in S. Gallinarum [12], it 
has been described in several members of S. enterica [8, 
9, 13, 29]. The number of genes conforming SPI-13 is not 
clearly defined. In fact, different authors have reported 
that this island contains 4 [8], 18 [13] or 22 genes [9]. In 
this study, we defined SPI-13 as the region encompass-
ing genes SEN2960 to SEN2966 in S. Enteritidis because 
these genes are adjacent to the tRNA-pheV gene and are 
flanked by nearly perfect direct repeats. Of note, these 7 
genes are replaced in the genome of typhoid Salmonella 
serovars such as S. Typhi and S. Paratyphi A by genes 
composing SPI-8 [8, 9, 14]. We investigated whether 
this genetic difference contributes to the differential 
intracellular survival reported for S. Enteritidis and S. 
Typhi in macrophages of murine and human origin [25].
Our results indicate that SPI-13 is required for inter-
nalization of S. Enteritidis in RAW264.7 macrophages. In 
agreement with this observation, a null mutant of gene 
SEN2961 also presented an internalization defect in 
HD-11 chicken macrophages [18]. Reduced internaliza-
tion by macrophages can affect S. Enteritidis pathogenic-
ity because bacterial uptake by phagocytes is required 
for systemic spread of the pathogen and, as mentioned, 
SPI-13 is required for systemic colonization of mice and 
chicken by different Salmonella serovars [9, 12, 19–22].
Our data also indicate that SPI-13 is not involved in 
the intracellular survival of S. Enteritidis in RAW264.7 
macrophages. These results do not agree with a recent 
study showing that deletion of SPI-13 (genes SEN2960 
to SEN2977) resulted in increased uptake and impaired 
survival of S. Enteritidis in RAW264.7 macrophages 
[20]. The discrepancies between results from both stud-
ies may be due to differences in the S. Enteritidis strain 
employed and the number of SPI-13 genes deleted (7 
vs. 18). Regarding this last point, the function of S. 
Enteritidis genes in the SEN2967-SEN2977 region (not 
included in our analysis) has been recently predicted 
and some of them may be required for intracellular sur-
vival in macrophages. For instance, SEN2973 encodes the 
Fig. 4 Contribution of SPI‑13 and SPI‑8 to the internalization and intracellular survival of S. Enteritidis and S. Typhi in human macrophages. Infection 
assays were conducted as described in “Methods” section to determine the internalization and intracellular survival of S. Enteritidis (a) and S. Typhi 
(b) strains in THP‑1 macrophages. Graphics show mean values of at least 3 independent assays ± SEM. Statistical significance was determined using 
a one‑way ANOVA with Dunnett’s test
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antiadaptor protein IraD, which in S. Typhimurium has 
been reported to increase the stability of the sigma stress 
factor RpoS during oxidative stress [30]. In addition, 
transposon insertion mutants of S. Enteritidis in genes 
SEN2972, SEN2976 and SEN2977 present systemic colo-
nization defects in mice [22]. Furthermore, the ∆SPI-13 
mutant used by the authors of the other study kept the 
kanamycin-resistance cassette replacing the island, which 
may generate polar effects on genes surrounding the site 
of mutation.
Remarkably, genes SEN2961-SEN2963 of S. Enter-
itidis are homologous to the ripABC operon of Y. pestis. 
This operon was originally described as required for Y. 
pestis survival and replication within activated mac-
rophages [31–33]. More recently, it was reported that Y. 
pestis ripABC operon encodes proteins with itaconate 
Co-A transferase, itaconil Co-A hydratase and citralil 
Co-A lyase activities, which together degrade itaconate 
and promote pathogenicity [23]. Itaconate is produced 
by macrophages in response to bacterial infection. This 
compound is a potent inhibitor of isocitrate lyase that 
blocks the glyoxylate cycle used by bacteria such as Sal-
monella and Mycobacterium to survive intracellularly 
[23, 34].
In contrast to our observations in RAW264.7 murine 
macrophages, SPI-13 was not required for internaliza-
tion or survival of S. Enteritidis in THP-1 human mac-
rophages. A possible explanation for these observations 
is that human macrophages produce itaconate at lower 
levels compared with mouse macrophages [34]. Hence, 
enzymes for itaconate degradation encoded in SPI-13 
would not be needed in these macrophages. This hypoth-
esis is supported by the fact that the genome of human 
pathogens S. Typhi and S. Paratyphi A do not contain 
SPI-13. Furthermore, our results showed that SPI-8 was 
not required for internalization or intracellular survival 
of S. Typhi in RAW264.7 murine macrophages or THP-1 
human macrophages. We hypothesize that SPI-8 has 
been maintained in the genome of typhoid Salmonella 
serovars because it encodes factors required during other 
steps of human infection. For instance, proteins encoded 
in SPI-8 conferring immunity to bacteriocins [14] could 
improve bacterial fitness of typhoid serovars in the 
human gut. Further studies are required to confirm this 
hypothesis.
Conclusions
In this study we evaluated the contribution of patho-
genicity islands SPI-13 and SPI-8 in the interaction 
of S. Enteritidis and S. Typhi with cultured murine 
(RAW264.7) and human (THP-1) macrophages. SPI-
13 is present in the genome of many serovars of Salmo-
nella enterica, including S. Enteritidis. However, this 
pathogenicity island is absent in the genome of typhoid 
serovars such as S. Typhi and S. Paratyphi C, which carry 
SPI-8 in the same genomic location. Our results indicate 
that SPI-13 is required for internalization of S. Enteritidis 
in murine but not in human macrophages. On the other 
hand, SPI-8 is not required for the internalization or sur-
vival of S. Typhi in human or murine macrophages. Thus, 
our results indicate different roles for SPI-13 and SPI-8 
during Salmonella infection.
Authors’ contributions
RAE, IC and CAS conceived and designed the experiments. RAE, FAA and IMU 
carried out the experiments. IC, CAS, RAE, CAS‑V, FAA and IMU analyzed and 
interpreted the results. IC, CAS, RAE and CAS‑V wrote the paper. All authors 
read and approved the final manuscript.
Author details
1 Laboratorio de Microbiología, Departamento de Bioquímica y Biología 
Molecular, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de 
Chile, Santos Dumont 964, Independencia, Santiago, Chile. 2 Department 
of Molecular Biology and Microbiology, Tufts University School of Medicine, 
Boston, MA 02111, USA. 
Acknowledgements
This study was supported by FONDECYT Grants 1110172 and 1140754 (to 
CAS). RAE, FAA and IMU were supported by CONICYT fellowships 21110114, 
22151395 and 21150005, respectively.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets generated and/or analyzed during the current study are available 
from the corresponding authors upon request.
Received: 4 October 2016   Accepted: 4 February 2017
References
 1. Brenner FW, Villar RG, Angulo FJ, Tauxe R, Swaminathan B. Salmonella 
nomenclature. J Clin Microbiol. 2000;38(7):2465–7.
 2. Reeves MW, Evins GM, Heiba AA, Plikaytis BD, Farmer JJ 3rd. Clonal nature 
of Salmonella typhi and its genetic relatedness to other Salmonellae as 
shown by multilocus enzyme electrophoresis, and proposal of Salmonella 
bongori comb. nov. J Clin Microbiol. 1989;27(2):313–20.
 3. Guard‑Petter J. The chicken, the egg and Salmonella enteritidis. Environ 
Microbiol. 2001;3(7):421–30.
 4. Patrick ME, Adcock PM, Gomez TM, Altekruse SF, Holland BH, Tauxe RV, 
Swerdlow DL. Salmonella Enteritidis infections, United States, 1985–1999. 
Emerg Infect Dis. 2004;10(1):1–7.
 5. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull 
World Health Organ. 2004;82(5):346–53.
 6. House D, Bishop A, Parry C, Dougan G, Wain J. Typhoid fever: pathogen‑
esis and disease. Curr Opin Infect Dis. 2001;14(5):573–8.
 7. Blondel CJ, Jimenez JC, Contreras I, Santiviago CA. Comparative genomic 
analysis uncovers 3 novel loci encoding type six secretion systems dif‑
ferentially distributed in Salmonella serotypes. BMC Genom. 2009;10:354.
 8. Desai PT, Porwollik S, Long F, Cheng P, Wollam A, Bhonagiri‑Palsikar 
V, Hallsworth‑Pepin K, Clifton SW, Weinstock GM, McClelland M. 
Additional file
Additional file 1: Table S1. Primers used in the present study.
Page 7 of 7Espinoza et al. Biol Res  (2017) 50:5 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Evolutionary genomics of Salmonella enterica subspecies. mBio. 
2013;4(2):e00579‑12.
 9. Haneda T, Ishii Y, Danbara H, Okada N. Genome‑wide identification of 
novel genomic islands that contribute to Salmonella virulence in mouse 
systemic infection. FEMS Microbiol Lett. 2009;297(2):241–9.
 10. Hayward MR, Jansen V, Woodward MJ. Comparative genomics of Sal-
monella enterica serovars Derby and Mbandaka, two prevalent serovars 
associated with different livestock species in the UK. BMC Genom. 
2013;14:365.
 11. Hensel M. Evolution of pathogenicity islands of Salmonella enterica. Int J 
Med Microbiol. 2004;294(2–3):95–102.
 12. Shah DH, Lee MJ, Park JH, Lee JH, Eo SK, Kwon JT, Chae JS. Identifica‑
tion of Salmonella gallinarum virulence genes in a chicken infection 
model using PCR‑based signature‑tagged mutagenesis. Microbiology. 
2005;151(Pt 12):3957–68.
 13. Thomson NR, Clayton DJ, Windhorst D, Vernikos G, Davidson S, Churcher 
C, Quail MA, Stevens M, Jones MA, Watson M, et al. Comparative genome 
analysis of Salmonella Enteritidis PT4 and Salmonella Gallinarum 287/91 
provides insights into evolutionary and host adaptation pathways. 
Genome Res. 2008;18(10):1624–37.
 14. Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, Wain J, Churcher 
C, Mungall KL, Bentley SD, Holden MT, et al. Complete genome sequence 
of a multiple drug resistant Salmonella enterica serovar Typhi CT18. 
Nature. 2001;413(6858):848–52.
 15. Eriksson S, Lucchini S, Thompson A, Rhen M, Hinton JC. Unravelling the 
biology of macrophage infection by gene expression profiling of intracel‑
lular Salmonella enterica. Mol Microbiol. 2003;47(1):103–18.
 16. Shi L, Adkins JN, Coleman JR, Schepmoes AA, Dohnkova A, Mottaz HM, 
Norbeck AD, Purvine SO, Manes NP, Smallwood HS, et al. Proteomic 
analysis of Salmonella enterica serovar Typhimurium isolated from RAW 
264.7 macrophages: identification of a novel protein that contributes to 
the replication of serovar Typhimurium inside macrophages. J Biol Chem. 
2006;281(39):29131–40.
 17. Srikumar S, Kroger C, Hebrard M, Colgan A, Owen SV, Sivasankaran SK, 
Cameron AD, Hokamp K, Hinton JC. RNA‑seq brings new insights to 
the intra‑macrophage transcriptome of Salmonella Typhimurium. PLoS 
Pathog. 2015;11(11):e1005262.
 18. Zhao Y, Jansen R, Gaastra W, Arkesteijn G, van der Zeijst BA, van Putten 
JP. Identification of genes affecting Salmonella enterica serovar enteritidis 
infection of chicken macrophages. Infect Immun. 2002;70(9):5319–21.
 19. Chakraborty S, Chaudhuri D, Balakrishnan A, Chakravortty D. Salmonella 
methylglyoxal detoxification by STM3117‑encoded lactoylglutathione 
lyase affects virulence in coordination with Salmonella pathogenic‑
ity island 2 and phagosomal acidification. Microbiology. 2014;160(Pt 
9):1999–2017.
 20. Elder JR, Chiok KL, Paul NC, Haldorson G, Guard J, Shah DH. The Salmo-
nella pathogenicity island 13 contributes to pathogenesis in streptomy‑
cin pre‑treated mice but not in day‑old chickens. Gut Pathog. 2016;8:16.
 21. Santiviago CA, Reynolds MM, Porwollik S, Choi SH, Long F, Andrews‑
Polymenis HL, McClelland M. Analysis of pools of targeted Salmonella 
deletion mutants identifies novel genes affecting fitness during competi‑
tive infection in mice. PLoS Pathog. 2009;5(7):e1000477.
 22. Silva CA, Blondel CJ, Quezada CP, Porwollik S, Andrews‑Polymenis HL, 
Toro CS, Zaldivar M, Contreras I, McClelland M, Santiviago CA. Infection of 
mice by Salmonella enterica serovar Enteritidis involves additional genes 
that are absent in the genome of serovar Typhimurium. Infect Immun. 
2012;80(2):839–49.
 23. Sasikaran J, Ziemski M, Zadora PK, Fleig A, Berg IA. Bacterial itaconate 
degradation promotes pathogenicity. Nat Chem Biol. 2014;10(5):371–7.
 24. Faucher SP, Curtiss R 3rd, Daigle F. Selective capture of Salmonella enterica 
serovar Typhi genes expressed in macrophages that are absent from 
the Salmonella enterica serovar Typhimurium genome. Infect Immun. 
2005;73(8):5217–21.
 25. Schwan WR, Huang XZ, Hu L, Kopecko DJ. Differential bacterial survival, 
replication, and apoptosis‑inducing ability of Salmonella serovars within 
human and murine macrophages. Infect Immun. 2000;68(3):1005–13.
 26. Valenzuela C, Ugalde JA, Mora GC, Alvarez S, Contreras I, Santiviago 
CA. Draft genome sequence of Salmonella enterica serovar Typhi strain 
STH2370. Genome Announc. 2014;2(1):e00104‑14.
 27. Datsenko KA, Wanner BL. One‑step inactivation of chromosomal genes 
in Escherichia coli K‑12 using PCR products. Proc Natl Acad Sci USA. 
2000;97(12):6640–5.
 28. Cherepanov PP, Wackernagel W. Gene disruption in Escherichia coli: 
TcR and KmR cassettes with the option of Flp‑catalyzed excision of the 
antibiotic‑resistance determinant. Gene. 1995;158(1):9–14.
 29. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, 
Porwollik S, Ali J, Dante M, Du F, et al. Complete genome sequence of Sal-
monella enterica serovar Typhimurium LT2. Nature. 2001;413(6858):852–6.
 30. Battesti A, Tsegaye YM, Packer DG, Majdalani N, Gottesman S. H‑NS 
regulation of IraD and IraM antiadaptors for control of RpoS degradation. 
J Bacteriol. 2012;194(10):2470–8.
 31. Pujol C, Grabenstein JP, Perry RD, Bliska JB. Replication of Yersinia 
pestis in interferon gamma‑activated macrophages requires ripA, a 
gene encoded in the pigmentation locus. Proc Natl Acad Sci USA. 
2005;102(36):12909–14.
 32. Torres R, Chim N, Sankaran B, Pujol C, Bliska JB, Goulding CW. Structural 
insights into RipC, a putative citrate lyase beta subunit from a Yersinia 
pestis virulence operon. Acta Crystallogr Sect F Struct Biol Cryst Commun. 
2012;68(Pt 1):2–7.
 33. Torres R, Swift RV, Chim N, Wheatley N, Lan B, Atwood BR, Pujol C, 
Sankaran B, Bliska JB, Amaro RE, et al. Biochemical, structural and molecu‑
lar dynamics analyses of the potential virulence factor RipA from Yersinia 
pestis. PLoS ONE. 2011;6(9):e25084.
 34. Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O, Binz T, 
Wegner A, Tallam A, Rausell A, et al. Immune‑responsive gene 1 protein 
links metabolism to immunity by catalyzing itaconic acid production. 
Proc Natl Acad Sci USA. 2013;110(19):7820–5.
